S
Song Wan
Researcher at The Chinese University of Hong Kong
Publications - 180
Citations - 6078
Song Wan is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Cardiopulmonary bypass & Mitral valve. The author has an hindex of 36, co-authored 172 publications receiving 5570 citations. Previous affiliations of Song Wan include Université libre de Bruxelles & Free University of Brussels.
Papers
More filters
Journal ArticleDOI
Inflammatory Response to Cardiopulmonary Bypass: Mechanisms Involved and Possible Therapeutic Strategies
TL;DR: In this paper, the authors reviewed the literature on the inflammatory response to CPB and discussed recent developments of therapeutic interventions aimed at attenuating the inflammatory cascade in perioperative injury, including corticosteroids, aprotinin, and antioxidants.
Journal ArticleDOI
Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow
Li Wang,Jiang-Yun Luo,Bochuan Li,Xiao Yu Tian,Li-Jing Chen,Yuhong Huang,Jian Liu,Dan Deng,Chi Wai Lau,Song Wan,Ding Ai,Kinglun Kingston Mak,Ka Kui Tong,Kin Ming Kwan,Nanping Wang,Jeng-Jiann Chiu,Yi Zhu,Yu Huang +17 more
TL;DR: The results indicate that integrin–Gα13–RhoA–YAP pathway holds promise as a novel drug target against atherosclerosis.
Journal ArticleDOI
Pulmonary Dysfunction After Cardiac Surgery
TL;DR: The potential benefits of maintaining ventilation and pulmonary artery perfusion during CPB warrant further investigation and the associated physiologic, biochemical, and histologic changes are reviewed.
Journal ArticleDOI
VATS lobectomy reduces cytokine responses compared with conventional surgery.
TL;DR: VATS lobectomy is associated with reduced postoperative release of both proinflammatory and antiinflammatory cytokines compared with the open approach, and the clinical significance of these findings remains to be fully elucidated.
Journal ArticleDOI
Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury.
TL;DR: Compared with conventional coronary artery bypass grafting, coronary revascularization without cardiopulmonary bypass is associated with reduced cytokine responses and less myocardial injury.